Blue Steens in October 2019
Click to read >>>
Justifying health insurance expenditure
It can be difficult for public health insurers to decide which medical interventions to cover. After all, it is the tax payers’ money that must be spent wisely and equitably across all patient groups.
Blue Steens in September 2019
Check out the monthly newsletter! It contains my last vlog, summarises Blue Steens’ latest posts and showcases some informative online content that I haven’t released elsewhere. Click to read >>>
Gender transition is in transition
Transgender health management has seen important advances in the recent past. Some notable remaining issues revolve around the standard of care and insurance coverage.
Impressions from Offshore Europe 2019
Snippets from the exhibition Comments on the video editor I used Lightworks to compose a family holiday video a few years ago. Since I’ve started vlogging, Offshore Europe was a neat opportunity to remind myself of how […]
Blue Steens in August 2019
Check out the new monthly newsletter! It contains my last vlog, summarises Blue Steens’ latest posts and showcases some informative online content that I haven’t released elsewhere. Click to read >>>
Organ donation part 4/4 – Making transplant organs
If current organ donation systems don’t adapt, alternative solutions to the global organ shortage will hopefully emerge from biotechnology. Making organ donation work? Organ shortage is costly in terms of human lives, public expenditure and lost productivity […]
Human test tubes paid to endure?
This is a comment on the following publication: Erik Malmqvist (2019) “Paid to Endure”: Paid Research Participation, Passivity, and the Goods of Work, The American Journal of Bioethics, 19:9, 11-20, DOI:10.1080/15265161.2019.1630498
Organ donation part 3/4 – The futures that never happened
Futures contracts for donations after death appear to ease major ethical concerns in the debate about payment for human organs. Yet, such proposals are incompatible with current law.